Inventor
MCKITTRICK BRIAN
US31 patents
⚠️ This page may combine multiple inventors who share the name “MCKITTRICK BRIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
17 patentsUS7763609B2Jul 27, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP38 citations95
US7592348B2Sep 22, 2009
Heterocyclic aspartyl protease inhibitors
SCHERING CORP16 citations92
US7868000B2Jan 11, 2011
Aspartyl protease inhibitors
SCHERING CORP18 citations84
US7592419B2Sep 22, 2009
Macrocyclic inhibitors of hepatitis C virus NS3-serine protease
SCHERING CORP11 citations84
US8012960B2Sep 6, 2011
Heterocyclic aspartyl protease inhibitors
SCHERING CORP5 citations74
US7763606B2Jul 27, 2010
Heterocyclic aspartyl protease inhibitors
SCHERING CORP5 citations74
US7973067B2Jul 5, 2011
Heterocyclic aspartyl protease inhibitors
SCHERING CORP6 citations73
US7468372B2Dec 23, 2008
Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
SCHERING CORP7 citations72
US6838466B2Jan 4, 2005
Compounds for the treatment of inflammatory disorders
SCHERING CORP10 citations72
US7759353B2Jul 20, 2010
Substituted spiro iminopyrimidinones as aspartyl protease inhibitors, compositions, and methods of treatment
SCHERING CORP5 citations63
US7759354B2Jul 20, 2010
Bicyclic guanidine derivatives as asparyl protease inhibitors, compositions, and uses thereof
SCHERING CORP5 citations63
US7560451B2Jul 14, 2009
Aspartyl protease inhibitors
SCHERING CORP5 citations63
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
US7459450B2Dec 2, 2008
Neuropeptide receptor modulators
SCHERING CORP5 citations60
US7598242B2Oct 6, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP0 citations51
US7504391B2Mar 17, 2009
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
SCHERING CORP1 citations51
US7034057B2Apr 25, 2006
Compounds for the treatment of inflammatory disorders
SCHERING CORP0 citations51
ZHU ZHAONING
6 patentsUS8691831B2Apr 8, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations83
US8829036B2Sep 9, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations82
US8691833B2Apr 8, 2014
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING7 citations82
US8242112B2Aug 14, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING2 citations62
US8178513B2May 15, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING1 citations62
US8202854B2Jun 19, 2012
Heterocyclic aspartyl protease inhibitors
ZHU ZHAONING0 citations52